Form 4 for SPRO Spero Therapeutics, Inc.
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0000950170-24-011501 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-05 | 2024-02-01 | SPRO | Keutzer Timothy | COO | A - Grant | $0.00 | +239.7K | 565.0K | +74% | $0 | |
| 2024-02-05 | 2024-02-02 | SPRO | Keutzer Timothy | COO | S - Sale | $1.36 | -31.0K | 534.0K | -5% | -$42.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | A | A | 239,731 | $0.00 | 565,021 | D | — | — | (F1) Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2025, subject to the Reporting Person's continued service through the applicable vesting date. |
| 2 | Common | Common Stock | 2024-02-02 | S | D | 30,971 | $1.36 | 534,050 | D | — | — | (F3) Represents the weighted average sales price per share. The shares sold at prices ranging from $1.36 to $1.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |